BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//International Health Economics Association - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://healtheconomics.org
X-WR-CALDESC:Events for International Health Economics Association
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260923T110000
DTEND;TZID=UTC:20260923T120000
DTSTAMP:20260519T155216
CREATED:20260507T202740Z
LAST-MODIFIED:20260519T143508Z
UID:335151-1790161200-1790164800@healtheconomics.org
SUMMARY:Health Inequality Aversion in Asia - Early Findings\, Methodological Challenges and Next Steps
DESCRIPTION:Add to Calendar! \nBackground: \nEquity in health has been a concern for long and has been central to aspirations for Universal Health Coverage (UHC)\, an objective enshrined in the Sustainable Development Goals (SDGs). Health Technology Assessment (HTA) has been identified as an approach to support UHC by use of evidence to inform policy on allocation of resources for health\, taking equity and other relevant considerations into account. Equity has featured in health economic research using various methodological approaches and over the past decade\, there have been innovations in methodological approaches to address equity through health economic evaluations\, such as Distributional Cost-effectiveness Analysis (DCEA) and Extended Cost-effectiveness Analysis (ECEA). \nThe Equity Informative Economic Evaluation Special Interest Group (SIG) of the the International Health Economics Association (iHEA) seeks to provide a platform for researchers and “encourage the development and synthesis of methods for using economic evaluation to address equity concerns”. More information is available at the following link: https://healtheconomics.org/sigs/eee/ \nTo further this mandate\, the EIEE SIG proposes hosting a series of webinars spanning the next two years. \nObjectives of the series: \n· To learn and share about equity informative health economic evaluations \n· To connect researchers working on equity informative health economic evaluations and form partnerships \n· To identify potential areas for future research and collaboration on equity informative health economic evaluations \n  \nThe first of the webinar series is: Health Inequality Aversion in Asia – Early Findings\, Methodological Challenges and Next Steps\, with the aim to: \n· To share findings from studies conducted on inequity \n· To learn about methodological challenges and potential applications \n· To identify potential areas for collaboration \nSpeakers: \n \nDr. Xiaoning He is an Associate Professor and Doctoral Supervisor at the School of Pharmaceutical Science and Technology\, Tianjin University.  \nShe was a visiting scholar at the University of Sheffield\, UK\, from September 2019 to March 2020. Her research interests cover pharmacoeconomics\, real-world evidence studies\, and health policy evaluation. She has served as the Principal Investigator (PI) for the General Program and Youth Program of the National Natural Science Foundation of China\, as well as for the General Program and Youth Program of the Tianjin Natural Science Foundation. Additionally\, she acts as a sub-project leader for the Major Program of the National Social Science Fund of China. She has authored more than 70 peer-reviewed journal articles\, among which over 40 are indexed in SCI/SSCI\, published in reputable journals including Value in Health and Pharmacoeconomics. She also contributed to the compilation of the China Guidelines for Pharmacoeconomic Evaluation 2025. She serves as Member and Secretary of the Pharmacoeconomics Committee of the Chinese Pharmaceutical Association\, Standing Committee Member of the Pharmacoeconomics Committee of the China Health Insurance Research Association\, and Member and Secretary of the Pharmacoeconomics Committee of the Tianjin Pharmaceutical Association. \n \nDr. Sitanshu Sekhar Kar is a Professor in the Department of Preventive and Social Medicine\, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)\, Puducherry.  \nHis areas of interest are Epidemiology\, NCD prevention & Health Promotion\, Health System Strengthening\, and Medical Education. He is leading the distributional cost-effective analysis study in India. He is passionate about capacity strengthening of early career researchers and led the inaugural programme through HTAsiaLink. He has contributed to the research community and was the Chief Editor of the International Journal of Medicine and Public Health (2013-2015)\, and a member of the Editorial Board of the Indian Journal of Community & Family Medicine and NTTC Bulletin. He is a reviewer of many national and international peer-reviewed journals like BMC Health\, Health Promotion International\, International Journal of Medicine and Public Health\, Indian Journal of Community Health\, IJOEM\, IJMS\, Journal of Pharmacology and Therapeutics & Indian Journal of Public Health. \n \nDr. Wanrudee Isaranuwatchai\, Secretary General and Senior Researcher of the Health Intervention and Technology Assessment Program Foundation (HITAP)\, Thailand and Affiliated Scientist at St. Michael’s Hospital\, and an Associate Professor at the Institute of Health Policy\, Management and Evaluation\, University of Toronto\, in Canada. \nHer research focuses on how to apply health economics and health technology assessment (HTA) in the real-world setting as well as how to advance methods in economic evaluation (EE). She has experience conducting EEs using various methods with specific interest in the potential of big data in health economics and HTA to support evidence generation and policy-making process. \nShe has also collaborated with researchers\, health professionals\, and policy-makers in various areas to help communicate the value of health initiatives using EE. She has contributed to the training on HTA to support health systems in Asia\, Africa\, and North America. Dr. Isaranuwatchai is dedicated to the creation and use of evidence in healthcare decision making. \n \nDr. Stéphane Verguet is an Associate Professor of Global Health in the Department of Global Health and Population at the Harvard T.H. Chan School of Public Health and a core faculty member of Harvard University’s Center for Health Decision Science.  \nHis research concerns health systems\, health economics\, and priority setting\, with significant contributions toward incorporating dimensions of equity into the economic evaluation of health policies and priority setting through the modeling of health benefit packages and intersectoral interventions\, via applied economic evaluations. He has co-chaired the Analytics & Metrics Community of Practice of the Research Consortium for School Health & Nutrition since 2021 and has contributed to the World Bank’s Disease Control Priorities since 2009\, most recently as a lead editor for the Universal Health Coverage volume of its fourth edition. He was also a Commissioner of The Lancet Global Health 2050 Commission. Verguet has degrees from the University of California\, Berkeley\, and the École Polytechnique and was previously on the faculty of the University of Washington. \n \nDr. Richard Cookson is a Professor at the Centre for Health Economics\, and Co-Director of the Equity in Health Policy (Equipol) research group. \nHe has helped pioneer “equity-informative” methods of policy analysis\, including distributional cost-effectiveness analysis; health equity indicators for healthcare quality assurance; and methods for investigating public concern for reducing health inequality; and is currently developing microsimulation methods for long-term childhood policy analysis.  He has co-chaired international working groups on equity\, worked in the UK Prime Minister’s Delivery Unit and served on various NHS advisory committees including the National Institute for Health and Care Excellence and the NHS Advisory Committee on Resource Allocation. Richard’s research focuses on equity in health and health care. Richard is an Honorary Public Health Academic\, Office for Health Improvement and Disparities. He has co-chaired various international working groups on equity; served on various NHS advisory groups including the National Institute for Health and Clinical Excellence (NICE) Technology Appraisal Committee 2002-7\, the Public Health Interventions Advisory Committee 2007-9\, the NHS Outcomes Framework Technical Advisory Committee 2012-16 and the NHS Advisory Committee for Resource Allocation 2017-21; and was seconded to the Prime Minister’s Delivery Unit in the Treasury in 2010. Richard holds a BA in Politics\, Philosophy and Economics and a DPhil in Economics from the University of York\, and an MPhil in Economics from the University of Oxford. \nResources\n\nHealth technology assessment – Global\nSelected\n\n\n\n\n\n\nWHO resolution 67.23 – Health intervention and technology assessment in support of universal health coverage\nSEA/RC66/R4 – Health intervention and technology assessment in support of universal health coverage\n\n\n\n\n\n\nO’Rourke B\, Oortwijn W\, Schuller T. The new definition of health technology assessment: A milestone in international collaboration. International journal of technology assessment in health care. 2020 Jun;36(3):187-90.\nDistributional cost-effectiveness analysis (DCEA) – Centre for Health Economics\, University of York\nTutorial: Extended Cost-Effectiveness Analysis
URL:https://healtheconomics.org/event/health-inequality-aversion-in-asia-early-findings-methodological-challenges-and-next-steps/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
END:VCALENDAR